Xiaolong Liu

机构：Fujian Medical University, Peking University, Beijing Jiaotong University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Sir Run Run Shaw Hospital, Guilin University of Technology, Guangxi Academy of Special Crops, Tianjin Infectious Diseases Hospital, Mengchao Hepatobiliary Hospital, Essen University Hospital, Tianjin haihe hospital, Guilin University of Electronic Technology, University of Duisburg-Essen, Zhejiang University, Lanzhou University, Henan Medical University, Fuzhou University · ORCID：0000-0002-3096-4981

发表论文 800 篇 · 总被引 23530 次 · h-index 77

代表论文

• Lab-on-Pipet-Tips: A Low-Cost Photothermal Immunosensing Platform for On-Site Testing of Acute Brain Injuries (2025 · ACS Sensors · 被引 17)
• HA/CD44–SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy (2026 · ACS Nano · 被引 6)
• Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy (2025 · Nature Communications · 被引 5)
• NIR-IIb fluorescence ratiometric imaging of tumor-associated neutrophils for immunotherapy efficacy monitoring and strategy optimization (2025 · Nature Communications · 被引 4)
• EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection (2025 · Gut · 被引 4)
• Selenium-Enriched Cerium Oxidative Nanoplatform for Colorectal Tumor Surgery with the Guidance of NIR II Fluorescent Bioimaging and Tumor-Microenvironment Triggered Synergistic Therapy (2025 · ACS Applied Materials & Interfaces · 被引 3)